Beyond the Fine Print: The Human Cost of Health Policy

Many clinicians share the same story. A patient leaves the doctor’s office with a diagnosis and a plan. But before treatment can begin, the insurance company says “no.” The test must be repeated. The medication must wait. The appeal could take weeks. For that patient, access is no longer a policy debate. It is a delay that could change their health outcome.

Patient access is often discussed in technical terms— coverage rules, benefit design, utilization management— but patients experience access in real time. It shows up as a delayed diagnosis, a denied prescription, or a treatment interrupted because the out-of-pocket cost is too high. These are not rare cases. They happen every day, across diseases and health plans, and they shape whether patients stay engaged in care or fall through the cracks.

Across the country, barriers to care are growing. The American Medical Association has reported that 94% of patients experience delays in care and 78% abandon treatment due to these hurdles, all while insurers make record profits.¹ Prior authorization, step therapy and high cost-sharing can slow down even routine treatment. A patient with worsening symptoms may spend weeks waiting for approval. Another may be told to “try and fail” a cheaper drug before getting the one their doctor originally prescribed. While these policies are often meant to control costs, they can cause harm when applied without flexibility or clear rules.

Clinicians see this play out daily. Patients live it daily. A health plan’s policy that looks reasonable on paper can mean missed doses, postponed procedures, or tough choices between paying for medicine or paying rent. When patients delay or abandon care because the system feels too hard to navigate, their health suffers—and costs often increase later to manage worsened conditions.

Fixing patient access requires more than cutting red tape. It requires listening to the people most affected. Clinician input helps explain how policies work, or fail, in practice. Patient input explains what those failures look like in real life. Patients can show how delays affect daily functioning, how costs shape decisions, and which barriers are most disruptive. Without both perspectives, policies risk solving the wrong problem.

Too often, patients and clinicians are asked for feedback only after decisions are made. That is too late. Policymakers need real-world insight early and often. Data matters, but so does context—how policies affect different communities, conditions and stages of life. After years of seeing the same access challenges resurface in different forms, one lesson remains clear: policy is strongest when it reflects lived experience from the start.

This is where collaborative advocacy plays a critical role. Organizations that bring patients and clinicians together help transform lived experiences into practical policy solutions. Through testimonies, public comments, education and direct engagement, these efforts help policymakers understand not only what a policy does, but how it feels to live under it.

For the past 2 decades, the Alliance for Patient Access was built on this idea: access works best when patients and clinicians help shape policy together.² Through clinician working groups, coalitions, affiliates and state chapters, the organization ensures real-world experience informs health care decisions. That mission—connecting lived experience to policymaking—has guided the organization for 20 years and remains just as urgent today.

Patient access is still a work in progress. As health care evolves, policy must keep up. Timely, appropriate care depends on listening— to clinicians, to patients, and to the realities they face every day. As the Alliance for Patient Access marks its 20th anniversary, that principle remains unchanged. Access is not an abstract goal. It is a measure of whether the system truly works for the people it serves.

Author Information

Josie Cooper is the executive director, Alliance for Patient Access.

References

1. Pickern JS. Prior authorizations and the adverse impact on continuity of care. Am J Manag Care. 2025;31(4): 163-165. doi:10.37765/ajmc.2025.89721
2. Alliance for Patient Access. Accessed May 7, 2026. https://allianceforpatientaccess.org/